Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal FistulasMichael De Gregorio, Nik S. Ding, Bonita Gu et al.|Clinical Gastroenterology and Hepatology|2021Cited by 36
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort studyCraig Haifer, Lena Thin, Yoon‐Kyo An et al.|The Medical Journal of Australia|2020Cited by 22
P1029 Janus Kinase Inhibitors for the Management of Acute Severe Ulcerative Colitis: A Multicentre StudyRobert Gilmore, Yoon‐Kyo An, Richard Fernandes et al.|Journal of Crohn s and Colitis|2025Cited by 3
P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohortYoon‐Kyo An, Richard Fernandes, Niamh Lindsay et al.|Journal of Crohn s and Colitis|2023Cited by 3
Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort studyCraig Haifer, Lena Thin, Ashish Srinivasan et al.|UWA Profiles and Research Repository (University of Western Australia)|2019Cited by 3